Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wiktor Szatkowski
Observed name:
W. Szatkowski
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
ORCID:
0000-0001-7682-7176
Observed ORCID:
0000-0001-7682-7176
OpenAlex ID:
A5031175777
Central Pathology Review in SENTIX, a Prospective Observational International Study on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (ENGOT-CX2)
2020
·
Kristyna Nemejcova
, Roman Kocian
, et al.
·
Cancers
·
22
PDF
Low-Dose Hypersensitive Response for Residual pATM and γH2AX Foci in Normal Fibroblasts of Cancer Patients
2017
·
Dorota Słonina
, Aleksandra Kowalczyk
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
20
The Assessment of Sentinel Lymph Node Mapping Methods in Endometrial Cancer
2025
·
Wiktor Szatkowski
, Karolina Pniewska
, et al.
·
Journal of Clinical Medicine
·
10
PDF
Clinicopathological Features and Risk Stratification of Multiple-Classifier Endometrial Cancers: A Multicenter Study from Poland
2025
·
Wiktor Szatkowski
, Małgorzata Nowak-Jastrząb
, et al.
·
Cancers
·
9
PDF
Challenges in lower limb lymphoedema assessment based on limb volume change: Lessons learnt from the SENTIX prospective multicentre study
2021
·
Martina Borčinová
, Volker Ragosch
, et al.
·
Gynecologic Oncology
·
9
Chemopotentiating effects of low-dose fractionated radiation on cisplatin and paclitaxel in cervix cancer cell lines and normal fibroblasts from patients with cervix cancer
2021
·
Dorota Słonina
, Damian Kabat
, et al.
·
DNA repair
·
7
Preoperative tumour size assessment in patients with early-stage cervical cancer: Final results of the SENTIX study
2025
·
Martina Borčinová
, Christhardt Köhler
, et al.
·
Gynecologic Oncology
·
6
Thyroid disorders as predictors of cemiplimab efficacy in recurrent/metastatic cervical cancer: real-world evidence from Poland
2025
·
Renata Pacholczak-Madej
, Maja Lisik-Habib
, et al.
·
Frontiers in Immunology
·
5
PDF
The role of technetium-99m isotope in sentinel lymph node identification in gynecological cancers
2025
·
Wiktor Szatkowski
, Dorota Słonina
, et al.
·
Reports of Practical Oncology & Radiotherapy
·
5
PDF
Analysis of Differences in the Classification of Endometrial Cancer Patients in Poland
2025
·
Wiktor Szatkowski
, Tomasz Kluz
, et al.
·
Cancers
·
4
PDF
Asymptomatic uterus-like mass (ULM) of the extraperitoneal space – a case report of a rare finding with unusual clinical presentation and review of the literature
2018
·
Konrad Muzykiewicz
, Paweł Majchrzak
, et al.
·
Polish Journal of Pathology
·
4
PDF
18-Hour Planar Scintigraphy Versus SPECT/CT for Sentinel Lymph Node Detection in Early-Stage Endometrial Cancer
2025
·
Wiktor Szatkowski
, Karolina Pniewska
, et al.
·
Cancers
·
3
PDF
959 Challenges in lower limb lymphoedema assessment based on limb volume change: lessons learnt from the SENTIX prospective multicentre study
2021
·
M. Borčinová
, R. Kocián
, et al.
·
International Journal of Gynecological Cancer
·
3
PDF
Comparison of effectiveness of treatment of patients with sporadic and germline BRCA1-related ovarian cancer
2016
·
Wiktor Szatkowski
, Konrad Muzykiewicz
, et al.
·
Ginekologia Polska
·
3
PDF
Prognostic factors in Polish patients with BRCA1-dependent ovarian cancer
2016
·
Wiktor Szatkowski
, Paweł Blecharz
, et al.
·
Hereditary Cancer in Clinical Practice
·
3
PDF
[The prevalence of BRCA1 mutations among families at high-risk of breast and ovarian cancer in province of Malopolska between 2004-2009].
2009
·
Paweł Blecharz
, Wiktor Szatkowski
, et al.
·
PubMed
·
3
Evaluation of inflammatory mediators as predictors ofprogression-free time (PFS) in patients with ovarian cancer(HGSOC) before and during treatment
2024
·
Urszula Rychlik
, Wiktor Szatkowski
, et al.
·
Diagnostyka Laboratoryjna
·
2
648 Tumour size assessment in patients with early-stage cervical cancer and its impact on a tailored management: final results of a prospective, international multicenter study SENTIX (CEEGOG CX-01; ENGOT-CX2)
2024
·
Roman Kocián
, Christhardt Köhler
, et al.
·
International Journal of Gynecological Cancer
·
2
[Clinical features and disease course in patients with BRCA1-dependent ovarian cancer].
2012
·
Paweł Blecharz
, Wiktor Szatkowski
, et al.
·
PubMed
·
2
Immune-related adverse events to predict outcomes in recurrent/metastatic cervical cancer treated with cemiplimab: Insights from a rescue access program in Poland.
2025
·
Renata Pacholczak-Madej
, Maja Lisik-Habib
, et al.
·
Journal of Clinical Oncology
·
1
Numerical Analysis of Sentinel Lymph Node Detection Using Technetium-99m: A Step Toward Objective Scintigraphy Evaluation in Oncology
2025
·
Wiktor Szatkowski
, Joanna Popieluch
, et al.
·
Bio-Algorithms and Med-Systems
·
1
Does FIGO 2023 meet clinical needs? An analysis of challenges and limitations
2025
·
Wiktor Szatkowski
, Aleksandra Kmieć
, et al.
·
Menopause Review/Przegląd Menopauzalny
·
1
PDF
Molecular prognostic factors in early-stage cervical adenocarcinoma
2018
·
Maciej Bodzek
, Paweł Blecharz
, et al.
·
Polish Journal of Pathology
·
1
PDF
Predictive value of systematic inflammatory response biomarkers (NLR, LMR, PLR) in patients with ovarian cancer.
2017
·
Urszula Rychlik
, Ewa Wójcik
, et al.
·
Diagnostyka Laboratoryjna
·
1
Molecular Profile of Advanced Endometrial Cancer (FIGO III–IV) in a Polish Multicentre Cohort: Clinicopathological Characterisation and Treatment Implications
2026
·
Wiktor Szatkowski
, Aleksandra Dudek
, et al.
·
Journal of Clinical Medicine
Show more works
View as search
Works count:
45
Citation count:
130
H-index:
6
I10-index:
3
Year
Topic
Type